SKA.docx
Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the.
Is There Still a Controversy About Stent Type for TASC C&D Lesions? Insights From COBEST Randomized Trial Aravinda Nanjundappa, MD, FACC, FSCAI Associate.
Disclosures u Dr. Spertus discloses that he is a founder of Health Outcomes Sciences () that disseminates and supports the PRISM tool..
“Acute Coronary Syndromes: Trials & Tribulations" Will Southern, M.D., M.S. Director of Hospitalist Services Associate Medical Director Weiler Division.
Colonic stenting: Single institution experience from a UK district general hospital.
PARIS Registry
